Conversations about metformins role in 2026 are shifting toward outcomes beyond glycemic control
Beyond that, OTR will be eligible for preclinical, development, regulatory and commercial milestone payments that could reach $2.5 billion with the majority representing commercial milestones. The Chinese company will also be in line for tiered single-digit royalties on worldwide sales should a drug eventually make it to market
In 2023, Johnson launched Rejuvenation Olympics, a leaderboard assessing one's speed of aging using DNA methylation
Do sulfur burps from Ozempic go away
Lets break down the science, set realistic timelines, and clear the confusion between expectation and realitywith honest insights from Dr
The status of the index AP as preferred or non-preferred was determined based on each states Medicaid formulary